enVVeno Medical board approves 1-for-35 reverse stock split

enVVeno Medical (NVNO) Corporation announced that the Company’s Board of Directors has approved a reverse stock split of its shares of common stock at a ratio of 1 for 35. The Reverse Stock Split will become effective at 12:01 a.m. Eastern time on January 20, 2026 and the Company’s common stock will open for trading on The Nasdaq Capital Market on a post-split basis on January 20, 2026 under the Company’s existing trading symbol “NVNO”. At such time, the Company’s common stock will also commence trading under a new CUSIP number 29415J205.